Tylenol may have a bot problem. In late September, President Trump directed the FDA to warn those who are pregnant against use of acetaminophen, the active ingredient in Tylenol, citing an unproven link between taking the medicine and rates of autism. (At the time, researchers said they needed more evidence; a more recent review published in the British Medical Journal found no link between use of acetaminophen and diagnoses of autism or ADHD.) Following President Trump’s directive, bots seem to have driven and amplified the conversation, according to a new report from narrative intelligence platform PeakMetrics. Nearly a third of posts about Tylenol from September 19 to November 4 on X were likely bot-driven, according to PeakMetrics, which reviewed 437,131 posts across X. According to Peak Metrics, 93% of the suspected bot activity was “reposting existing content, extending reach and lifespan of emotionally charged narratives.” More than half (65.8%) of the conversation on X about Tylenol was unfavorable toward the brand, according to PeakMetrics, which also noted that, across those posts, “themes of parental guilt, loss of trust, and frustration toward pharmaceutical companies” were prominent. Keep reading on Marketing Brew.—KM |